LRATD2 and prostate neoplasm: Of note, by extracting and analyzing genomic and mRNA data from 194 prostate tumors with copy number alterations (CNA) from the “MSKCC, Cancer Cell 2010” dataset [45] within cBioPortal, we were able to show that FAM84B gene amplification alone and with its mRNA upregulation (Supplementary Figure 9A) associates with decreases in DFS (Figure 9A).